•    Large payors and their affiliates who will benefit from improved outcomes and cost savings

•    Pharmaceutical and device companies who will benefit from a stronger brand position in their      marketplace and enhanced and less costly data collection in their clinical trials

•    Contract research organizations who will benefit from more reliable and less costly data      collection in their clinical trials